Lupin Pharmaceuticals Initiates Recall of Millions of Contaminated Eye Drop Bottles
Lupin Pharmaceuticals has voluntarily recalled over 2.5 million bottles of prednisolone acetate ophthalmic suspension. The prescription eye drops, used for inflammation, were found to contain an undisclosed contaminant. This Class II recall indicates a defective product, though it is not immediately life-threatening, but still poses a health concern for users.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.